Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
9.58
-0.15 (-1.54%)
Sep 24, 2026, 3:04 PM CST
SHE:002399 Market Cap
SHE:002399 has a market cap or net worth of 12.69 billion as of September 25, 2026. Its market cap has decreased by -21.31% in one year.
Market Cap
12.69B
Enterprise Value
12.20B
Revenue
5.24B
Ranking
n/a
PE Ratio
69.27
Stock Price
9.58
ChartMarket Cap Chart
Since May 6, 2010, SHE:002399's market cap has decreased from 70.09B to 12.69B, a decrease of -81.89%. That is a compound annual growth rate of -9.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 12.69B | -19.35% |
| Dec 31, 2025 | 15.73B | 11.19% |
| Dec 31, 2024 | 14.15B | -7.78% |
| Dec 29, 2023 | 15.34B | -10.21% |
| Dec 30, 2022 | 17.09B | -25.00% |
| Dec 31, 2021 | 22.79B | -3.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fujian Cosunter Pharmaceutical | 14.23B |
| Zhejiang Jiuzhou Pharmaceutical | 14.18B |
| Guobang Pharma | 13.97B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 13.94B |
| Zhejiang Hisun Pharmaceutical | 13.24B |
| Porton Pharma Solutions | 12.78B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.43B |
| PharmaBlock Sciences (Nanjing) | 12.13B |